{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T17:04:35Z","timestamp":1775149475752,"version":"3.50.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,21]],"date-time":"2020-09-21T00:00:00Z","timestamp":1600646400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,21]],"date-time":"2020-09-21T00:00:00Z","timestamp":1600646400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s00535-020-01727-2","type":"journal-article","created":{"date-parts":[[2020,9,21]],"date-time":"2020-09-21T18:03:13Z","timestamp":1600711393000},"page":"54-66","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Impact of acute kidney injury on prognosis and the effect of tolvaptan in patients with hepatic ascites"],"prefix":"10.1007","volume":"56","author":[{"given":"Yasunari","family":"Hiramine","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirofumi","family":"Uto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiichi","family":"Mawatari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuji","family":"Kanmura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Imamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Hiwaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Saishoji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manei","family":"Oku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Tokushige","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeho","family":"Maenohara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akio","family":"Ido","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,21]]},"reference":[{"key":"1727_CR1","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/hep.1840070124","volume":"7","author":"P Gines","year":"1987","unstructured":"Gines P, Quintero E, Arroyo V, et al. Compensated cirrhosis: natural history and prognostic factors. Hepatology. 1987;7:122\u20138.","journal-title":"Hepatology"},{"key":"1727_CR2","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jhep.2010.03.001","volume":"53","author":"European Association for the Study of the Liver","year":"2010","unstructured":"European Association for the Study of the Liver. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol. 2010;53:397\u2013417.","journal-title":"J Hepatol"},{"key":"1727_CR3","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0168-8278(05)80451-9","volume":"17","author":"V Arroyo","year":"1993","unstructured":"Arroyo V, Gines P. Mechanism of sodium retention and ascites formation in cirrhosis. J Hepatol. 1993;17:24\u20138.","journal-title":"J Hepatol"},{"key":"1727_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/kisup.2012.1","volume":"2","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group","year":"2012","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical practice guideline for acute kidney injury. Kidney Int. 2012;2:1\u2013138.","journal-title":"Kidney Int"},{"key":"1727_CR5","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1016\/S0140-6736(16)30239-2","volume":"387","author":"JA Kellum","year":"2016","unstructured":"Kellum JA, Ronco C, Bellomo R. Acute kidney disease and the community. Lancet. 2016;387:1974\u20136.","journal-title":"Lancet"},{"key":"1727_CR6","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1002\/hep.22605","volume":"48","author":"G Garcia-Tsao","year":"2008","unstructured":"Garcia-Tsao G, Parikh CR, Viola A. Acute kidney injury in cirrhosis. Hepatology. 2008;48:2064\u201377.","journal-title":"Hepatology"},{"key":"1727_CR7","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/hep.26980","volume":"60","author":"JM Belcher","year":"2014","unstructured":"Belcher JM, Sanyal AJ, Peixoto AJ, et al. Kidney biomarkers and differential diagnosis of patients with cirrhosis and acute kidney injury. Hepatology. 2014;60:622\u201332.","journal-title":"Hepatology"},{"key":"1727_CR8","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.jhep.2013.04.036","volume":"59","author":"C Fagundes","year":"2013","unstructured":"Fagundes C, Barreto R, Guevara M, et al. A modified acute kidney injury classification for diagnosis and risk stratification of impairment of kidney function in cirrhosis. J Hepatol. 2013;59:474\u201381.","journal-title":"J Hepatol"},{"key":"1727_CR9","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.jhep.2013.03.039","volume":"59","author":"S Piano","year":"2013","unstructured":"Piano S, Rosi S, Maresio G, et al. Evaluation of the Acute Kidney Injury Network criteria in hospitalized patients with cirrhosis and ascites. J Hepatol. 2013;59:482\u20139.","journal-title":"J Hepatol"},{"key":"1727_CR10","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1136\/gutjnl-2011-301255","volume":"62","author":"CD Tsien","year":"2013","unstructured":"Tsien CD, Rabie R, Wong F. Acute kidney injury in decompensated cirrhosis. Gut. 2013;62:131\u20137.","journal-title":"Gut"},{"key":"1727_CR11","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1136\/gutjnl-2014-308874","volume":"64","author":"P Angeli","year":"2015","unstructured":"Angeli P, Gines P, Wong F, et al. Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites. Gut. 2015;64:531\u20137.","journal-title":"Gut"},{"key":"1727_CR12","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jhep.2018.03.024","volume":"69","author":"European Association for the Study of the Liver","year":"2018","unstructured":"European Association for the Study of the Liver. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J Hepatol. 2018;69:406\u201360.","journal-title":"J Hepatol"},{"key":"1727_CR13","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.jhep.2019.12.020","volume":"72","author":"O Bassegoda","year":"2020","unstructured":"Bassegoda O, Huelin P, Ariza X, et al. Development of chronic kidney disease after acute kidney injury in patients with cirrhosis is common and impairs clinical outcomes. J Hepatol. 2020;72:1132\u20139.","journal-title":"J Hepatol"},{"key":"1727_CR14","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1002\/hep.30058","volume":"68","author":"G Cullaro","year":"2018","unstructured":"Cullaro G, Park M. \u201cNormal\u201d creatinine levels predict persistent kidney injury and waitlist mortality in outpatients with cirrhosis. Hepatology. 2018;68:1953\u201360.","journal-title":"Hepatology"},{"key":"1727_CR15","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jhep.2018.12.008","volume":"70","author":"P Huelin","year":"2019","unstructured":"Huelin P, Sol\u00e0 E, Elia C, et al. Neutrophil gelatinase-associated lipocalin for assessment of acute kidney injury in cirrhosis: a prospective study. Hepatology. 2019;70:319\u201333.","journal-title":"Hepatology"},{"issue":"Suppl 3","key":"1727_CR16","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1097\/00005344-199322003-00007","volume":"22","author":"G Laffi","year":"1993","unstructured":"Laffi G, La Villa G, Carloni V, et al. Loop diuretic therapy in liver cirrhosis with ascites. J Cardiovasc Pharmacol. 1993;22(Suppl 3):S51\u2013S5858.","journal-title":"J Cardiovasc Pharmacol"},{"key":"1727_CR17","doi-asserted-by":"crossref","first-page":"F273","DOI":"10.1152\/ajprenal.00195.2005","volume":"290","author":"LC Costello-Boerrigter","year":"2006","unstructured":"Costello-Boerrigter LC, Smith WB, Boerrigter G, et al. Vasopressin-2-receptor antagonism augments water excretion without changes in renal hemodynamics or sodium and potassium excretion in human heart failure. Am J Physiol Renal Physiol. 2006;290:F273\u2013F278278.","journal-title":"Am J Physiol Renal Physiol"},{"key":"1727_CR18","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1253\/circj.CJ-14-0244","volume":"78","author":"T Imamura","year":"2014","unstructured":"Imamura T, Kinugawa K, Fujino T, et al. Increased urine aquaporin-2 relative to plasma arginine vasopressin is a novel marker of response to tolvaptan in patients with decompensated heart failure. Circ J. 2014;78:2240\u20139.","journal-title":"Circ J"},{"key":"1727_CR19","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/hepr.12098","volume":"44","author":"I Sakaida","year":"2014","unstructured":"Sakaida I, Kawazoe S, Kajimura K, et al. Tolvaptan for improvement of hepatic edema: A phase 3, multicenter, randomized, double-blind, placebo-controlled trial. Hepatol Res. 2014;44:73\u201382.","journal-title":"Hepatol Res"},{"key":"1727_CR20","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1007\/s00535-015-1052-5","volume":"50","author":"I Sakaida","year":"2015","unstructured":"Sakaida I, Nakajima K, Okita K, et al. Can serum albumin level affect the pharmacological action of tolvaptan in patients with liver cirrhosis? A post hoc analysis of previous clinical trials in Japan. J Gastroenterol. 2015;50:1047\u201353.","journal-title":"J Gastroenterol"},{"key":"1727_CR21","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s00535-016-1216-y","volume":"51","author":"H Fukui","year":"2016","unstructured":"Fukui H, Saito H, Ueno Y, et al. Evidence-based clinical practice guidelines for liver cirrhosis 2015. J Gastroenterol. 2016;51:629\u201350.","journal-title":"J Gastroenterol"},{"key":"1727_CR22","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1111\/jgh.14524","volume":"34","author":"T Iwamoto","year":"2019","unstructured":"Iwamoto T, Maeda M, Saeki I, Hidaka I, Tajima K, Ishikawa T, et al. Analysis of tolvaptan non-responders and outcomes of tolvaptan treatment of ascites. J Gastroenterol Hepatol. 2019;34:1231\u20135.","journal-title":"J Gastroenterol Hepatol"},{"key":"1727_CR23","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1007\/s00535-020-01691-x","volume":"55","author":"I Sakaida","year":"2020","unstructured":"Sakaida I, Terai S, Kurosaki M, Okada M, Hirano T, Fukuta Y. Real-world effectiveness and safety of tolvaptan in liver cirrhosis patients with hepatic edema: results from a post-marketing surveillance study (START study). J Gastroenterol. 2020;55:800\u201310.","journal-title":"J Gastroenterol"},{"key":"1727_CR24","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/s00535-017-1366-6","volume":"53","author":"Y Hiramine","year":"2018","unstructured":"Hiramine Y, Uojima H, Nakanishi H, Hiramatsu A, Iwamoto T, Kimura M, et al. Response criteria of tolvaptan for the treatment of hepatic edema. J Gastroenterol. 2018;53:258\u201368.","journal-title":"J Gastroenterol"},{"key":"1727_CR25","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1111\/hepr.13337","volume":"49","author":"Y Hiramine","year":"2019","unstructured":"Hiramine Y, Uto H, Mawatari S, et al. Effect of tolvaptan on the prognosis of patients with hepatic ascites. Hepatol Res. 2019;49:765\u201377.","journal-title":"Hepatol Res"},{"key":"1727_CR26","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1038\/ajg.2017.122","volume":"112","author":"F Wong","year":"2017","unstructured":"Wong F, O'Leary JG, Reddy KR, et al. Acute kidney injury in cirrhosis: baseline serum creatinine predicts patient outcomes. Am J Gastroenterol. 2017;112:1103\u201310.","journal-title":"Am J Gastroenterol"},{"key":"1727_CR27","doi-asserted-by":"crossref","first-page":"e14475","DOI":"10.1097\/MD.0000000000014475","volume":"98","author":"T Umemura","year":"2019","unstructured":"Umemura T, Joshita S, Shibata S, et al. Renal impairment is associated with increased risk of mortality in patients with cirrhosis: a retrospective cohort study. Medicine (Baltimore). 2019;98:e14475.","journal-title":"Medicine (Baltimore)"},{"key":"1727_CR28","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1056\/NEJMra0809139","volume":"361","author":"P Gin\u00e8s","year":"2009","unstructured":"Gin\u00e8s P, Schrier RW. Renal failure in cirrhosis. N Engl J Med. 2009;361:1279\u201390.","journal-title":"N Engl J Med"},{"issue":"5 Pt 1","key":"1727_CR29","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/0016-5085(83)90211-1","volume":"84","author":"TD Boyer","year":"1983","unstructured":"Boyer TD, Warnock DG. Use of diuretics in the treatment of cirrhotic ascites. Gastroenterology. 1983;84(5 Pt 1):1051\u20135.","journal-title":"Gastroenterology"},{"key":"1727_CR30","doi-asserted-by":"crossref","first-page":"94334","DOI":"10.1172\/jci.insight.94334","volume":"2","author":"G Kanzaki","year":"2017","unstructured":"Kanzaki G, Puelles VG, Cullen-McEwen LA, et al. New insights on glomerular hyperfiltration: a Japanese autopsy study. JCI Insight. 2017;2:94334.","journal-title":"JCI Insight"},{"key":"1727_CR31","first-page":"164","volume":"23","author":"V Arroyo","year":"1996","unstructured":"Arroyo V, Gin\u00e8s P, Gerbes AL, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. Internat Ascites Club Hepatol. 1996;23:164\u201376.","journal-title":"Internat Ascites Club Hepatol"},{"key":"1727_CR32","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/ehf2.12221","volume":"5","author":"T Okabe","year":"2018","unstructured":"Okabe T, Yakushiji T, Kido T, et al. The association between high-dose loop diuretic use at discharge and cardiovascular mortality in patients with heart failure. ESC Heart Fail. 2018;5:87\u201394.","journal-title":"ESC Heart Fail"},{"key":"1727_CR33","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1111\/jgh.14965","volume":"35","author":"M Atsukawa","year":"2020","unstructured":"Atsukawa M, Tsubota A, Takaguchi K, et al. Analysis of factors associated with the prognosis of cirrhotic patients who were treated with tolvaptan for hepatic edema. J Gastroenterol Hepatol. 2020;35:1229\u2013377.","journal-title":"J Gastroenterol Hepatol"},{"key":"1727_CR34","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1001\/jama.288.20.2547","volume":"288","author":"RL Mehta","year":"2002","unstructured":"Mehta RL, Pascual MT, Soroko S, et al. PICARD Study Group Diuretics, mortality, and nonrecovery of renal function in acute renal failure. JAMA. 2002;288:2547\u201353.","journal-title":"JAMA"},{"key":"1727_CR35","first-page":"154","volume":"56","author":"CJ Kapelios","year":"2015","unstructured":"Kapelios CJ, Kaldara E, Ntalianis A, et al. High furosemide dose has detrimental effects on survival of patients with stable heart failure. Hellenic J Cardiol. 2015;56:154\u20139.","journal-title":"Hellenic J Cardiol"},{"key":"1727_CR36","first-page":"2210","volume":"16","author":"NF Vaz","year":"2019","unstructured":"Vaz NF, da Cunha VNR, Cunha-Silva M, et al. Evolution of diagnostic criteria for acute kidney injury in patients with decompensated cirrhosis: a prospective study in a tertiary university hospital. Clin Res Hepatol Gastroenterol. 2019;16:2210\u20137401.","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"1727_CR37","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nrneph.2009.213","volume":"6","author":"JR Prowle","year":"2010","unstructured":"Prowle JR, Echeverri JE, Ligabo EV, et al. Fluid balance and acute kidney injury. Nat Rev Nephrol. 2010;6:107\u201315.","journal-title":"Nat Rev Nephrol"},{"key":"1727_CR38","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1056\/NEJMoa1005419","volume":"364","author":"GM Felker","year":"2011","unstructured":"Felker GM, Lee KL, Bull DA, et al. Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med. 2011;364:797\u2013805.","journal-title":"N Engl J Med"},{"key":"1727_CR39","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/hepr.12700","volume":"47","author":"T Mori","year":"2017","unstructured":"Mori T, Ohsaki Y, Oba-Yabana I, et al. Diuretic usage for protection against end-organ damage in liver cirrhosis and heart failure. Hepatol Res. 2017;47:11\u201322.","journal-title":"Hepatol Res"},{"key":"1727_CR40","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jhep.2012.03.018","volume":"57","author":"T Serst\u00e9","year":"2012","unstructured":"Serst\u00e9 T, Gustot T, Rautou PE, et al. Severe hyponatremia is a better predictor of mortality than MELDNa in patients with cirrhosis and refractory ascites. J Hepatol. 2012;57:274\u201380.","journal-title":"J Hepatol"},{"key":"1727_CR41","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1002\/hep.21412","volume":"44","author":"P Angeli","year":"2006","unstructured":"Angeli P, Wong F, Watson H, et al. Hyponatremia in cirrhosis: Results of a patient population survey. Hepatology. 2006;44:1535\u201342.","journal-title":"Hepatology"},{"key":"1727_CR42","doi-asserted-by":"crossref","first-page":"8062","DOI":"10.3748\/wjg.v23.i45.8062","volume":"23","author":"H Uojima","year":"2017","unstructured":"Uojima H, Hidaka H, Nakayama T, et al. Efficacy of combination therapy with natriuretic and aquaretic drugs in cirrhotic ascites patients: a randomized study. World J Gastroenterol. 2017;23:8062\u201372.","journal-title":"World J Gastroenterol"},{"key":"1727_CR43","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s00535-019-01623-4","volume":"55","author":"M Namba","year":"2020","unstructured":"Namba M, Hiramatsu A, Aikata H, et al. Management of refractory ascites attenuates muscle mass reduction and improves survival in patients with decompensated cirrhosis. J Gastroenterol. 2020;55:217\u201326.","journal-title":"J Gastroenterol"},{"key":"1727_CR44","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1016\/j.cgh.2019.11.035","volume":"18","author":"AL Mindikoglu","year":"2020","unstructured":"Mindikoglu AL, Hernaez R, Liu Y, et al. Renal trajectory patterns are associated with post-discharge mortality in patients with cirrhosis and acute kidney injury. Clin Gastroenterol Hepatol. 2020;18:1858\u201366.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"1727_CR45","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1056\/NEJMra1214243","volume":"371","author":"LS Chawla","year":"2014","unstructured":"Chawla LS, Eggers PW, Star RA, et al. Acute kidney injury and chronic kidney disease as interconnected syndromes. N Engl J Med. 2014;371(1):58\u201366.","journal-title":"N Engl J Med"},{"key":"1727_CR46","doi-asserted-by":"crossref","first-page":"e0174649","DOI":"10.1371\/journal.pone.0174649","volume":"12","author":"Y Komiyama","year":"2017","unstructured":"Komiyama Y, Kurosaki M, Nakanishi H, Takahashi Y, Itakura J, Yasui Y, et al. Prediction of diuretic response to tolvaptan by a simple, readily available spot urine Na\/K ratio. PLoS ONE. 2017;12:e0174649.","journal-title":"PLoS ONE"},{"key":"1727_CR47","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1159\/000439101","volume":"33","author":"M Kudo","year":"2015","unstructured":"Kudo M, Kitano M, Sakurai T, et al. General rules for the clinical and pathological study of primary liver cancer, nationwide follow-up survey and clinical practice guidelines: the outstanding achievements of the liver cancer study group of Japan. Dig Dis. 2015;33:765\u201370.","journal-title":"Dig Dis"}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-020-01727-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00535-020-01727-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-020-01727-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T10:43:45Z","timestamp":1668854625000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00535-020-01727-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,21]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["1727"],"URL":"https:\/\/doi.org\/10.1007\/s00535-020-01727-2","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"value":"0944-1174","type":"print"},{"value":"1435-5922","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,21]]},"assertion":[{"value":"19 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}